Title:
Ｔ細胞活性化のための抗体
Document Type and Number:
Japanese Patent JP2022539527
Kind Code:
A
Abstract:
本願明細書において、ＣＤ１３７に結合する抗原結合領域を含む抗体を提供する。本願明細書において、ＣＤ１３７に結合する第１の抗原結合領域と、免疫チェックポイント分子、免疫刺激分子、又は腫瘍抗原に結合する第２の抗原結合領域とを含む二重特異性抗体もまた提供する。当該抗体を含む医薬組成物、及びがんを治療する方法を提供する。【選択図】図１３
Inventors:
Her Chen-Horn
Lee Woo Jeong-Choi
Su Ching-Xuan
Huang Po-Ling
Lee Woo Jeong-Choi
Su Ching-Xuan
Huang Po-Ling
Application Number:
JP2021576891A
Publication Date:
September 12, 2022
Filing Date:
June 24, 2020
Export Citation:
Assignee:
AP Biosciences, Inc.
International Classes:
C12N15/13; A61K39/395; A61K45/00; A61K47/68; A61P35/00; A61P35/02; C07K16/28; C07K16/46; C12N15/62
Attorney, Agent or Firm:
Shimizu Hatsushi
Masao Haruna
Hirotaka Yamaguchi
Shun Jinbe
Ryuichi Inoue
Toshimitsu Sato
Koichi Niimi
Tomohiko Kobayashi
Hideki Kodera
Masato Ozeki
Kazuya Kawamoto
Masao Haruna
Hirotaka Yamaguchi
Shun Jinbe
Ryuichi Inoue
Toshimitsu Sato
Koichi Niimi
Tomohiko Kobayashi
Hideki Kodera
Masato Ozeki
Kazuya Kawamoto
Previous Patent: Induction heating device with gas permeable segmented induction heating element
Next Patent: FLT3L-FC fusion protein and method of use
Next Patent: FLT3L-FC fusion protein and method of use